Edition:
United Kingdom

Editas Medicine Inc (EDIT.OQ)

EDIT.OQ on NASDAQ Stock Exchange Global Select Market

30.10USD
21 Sep 2018
Change (% chg)

$-2.47 (-7.58%)
Prev Close
$32.57
Open
$33.01
Day's High
$33.01
Day's Low
$29.88
Volume
740,011
Avg. Vol
277,781
52-wk High
$45.02
52-wk Low
$19.08

Chart for

About

Editas Medicine, Inc. is a genome editing company. It is engaged in treating patients with genetically defined diseases by correcting their disease-causing genes. It operates through developing and commercializing genome editing technology segment. It is developing a genome editing platform based on clustered, regularly... (more)

Overall

Beta: --
Market Cap(Mil.): $1,043.82
Shares Outstanding(Mil.): 41.74
Dividend: --
Yield (%): --

Financials

  EDIT.OQ Industry Sector
P/E (TTM): -- 85.68 32.76
EPS (TTM): -3.19 -- --
ROI: -42.42 1.79 14.61
ROE: -63.35 3.28 16.33

BRIEF-Editas Medicine Reports Q1 Loss Per Share Of $0.67

* EDITAS MEDICINE ANNOUNCES FIRST QUARTER 2018 RESULTS AND UPDATE

03 May 2018

BRIEF-Editas Medicine Names James Mullen As Chairman Of Board

* EDITAS MEDICINE NAMES JAMES C. MULLEN AS CHAIRMAN OF THE BOARD OF DIRECTORS

28 Mar 2018

Earnings vs. Estimates